Helius Medical Technologies Inc Class A (HSDT) Stock Analysis

Helius Medical Technologies Inc Class A (HSDT) is a publicly traded company in the HEALTHCARE sector. It trades at $1.60, carries a market capitalization of $111.23M, a price-to-earnings ratio of 0.01. This page summarizes the public market data, fundamentals, and frequently asked questions for HSDT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

About Helius Medical Technologies Inc Class A

Helius Medical Technologies, Inc. (HSDT) is a pioneering neurotechnology company focused on developing and commercializing non-invasive therapies designed to alleviate symptoms related to neurological disorders and trauma. The company leverages cutting-edge technologies to meet significant unmet medical needs in the neurorehabilitation market, demonstrating a strong commitment to improving patient outcomes and enhancing quality of life for individuals affected by these conditions. Based in Ne...

GNG Research Analysis

GNG Research scores Helius Medical Technologies Inc Class A (HSDT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for HSDT.

Frequently Asked Questions

Does HSDT pay dividends?

Helius Medical Technologies Inc Class A (HSDT) does not currently pay a regular dividend.

What is HSDT's P/E ratio?

Helius Medical Technologies Inc Class A has a price-to-earnings (P/E) ratio of 0.01.

What is HSDT's market cap?

Helius Medical Technologies Inc Class A (HSDT) has a market capitalization of $111.23M with a current stock price of $1.60.